Rimonabant acomplia information
It looks like that FDA is not in rush at all. Rimonabant acomplia has been approved for sale in Mexico since Nov. 9th. after couple of EU states /like UK/ this drug finally arrived to America. This diet pil …
Archive for: August 2007
Acomplia Rimonabant
Acomplia is the brand name of the medication while Rimonabant is the name of its active ingredient. Acomplia (Rimonabant), after its launch in the June 2006, has conquered a vast portion of weight loss drug market. This success of Rimonabant …
Diet Drug rimonabant - News About Weight-Loss Drug rimonabant
Top Marketeer to Promote Taranabant, Competitor to Acomplia…
Acomplia (Rimonabant)
Under development by Sanofi-Aventis, Acomplia (rimonabant) is a selective CB1 endocannabinoid receptor antagonist indicated for the treatment of obesity.
“Acomplia is a selective CB1 endocannabinoid receptor antagonist.”
It works by blocking endogenous cannabinoid binding to neuronal CB1 receptors. Activation of these …
Acomplia Rimonabant diet treatment helps weight loss
Accomplia
Rimonabant diet treatment blocks circuitry in brain that gives body cravingsAcomplia Rimonabant ( accomplia ), is a new treatment which helps …
Buying rimonabant cost structure
rimonabant(rimonabant cost) is the product launched by Sanofi-Aventis of France. This high efficacy appetite suppressant was launched in the UK anti-obesity drug market in the month of June. The drug is a ray of hope for million suffering from obesity. …
Rimonabant diet pill in us and in uk
Since the limited launch of the drug in the EU in the third quarter, rimonabant diet pill sales have been roughly $15 million. But sales should increase much faster as Sanofi gets the word out about rimonabant via marketing and …
Serenade rimonabant -Confirms Efficacy of Rimonabant in Diabetes
SERENADE Trial
SERENADE (Study Evaluating Rimonabant Efficacy in Drug Naive Diabetic Patients) was a six-month phase IIIb, …
Acomplia -Rimonabant Canada
The main task of Acomplia Rimonabant diet pills is that it blocks the CB-1 receptors, which are found in brain in addition to some of the body’s peripheral tissues such as fat cells. Apart from its benefits in weight loss …
Acomplia Rimonabant Mexico
Acomplia Rimonabant Mexico
The world’s third largest drug maker, French drug maker Sanofi-Aventis obesity drug, Acomplia (rimonabant) has approved to sell in Mexico. The first approval of the drug in North America. Acomplia Mexican approval has a diabetes indication, which is …